Company
Melbourne, VIC
Every investor coverage indicates participated in a round Royal Melbourne Hospital raised.
Companies Royal Melbourne Hospital acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Royal Melbourne Hospital. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Denteric has begun recruiting early Alzheimer's patients for a Phase I trial of its gingipain-targeting therapy GPV381, with funding from the CUREator+ Dementia program and the Medical Research Future Fund.
Roundup of eight funding deals: Synchron's Series D, plus raises by Lumonus AI, Hullbot, Nbryo, Cytophenix, Giftbee, Understanding Zoe and Zeligate, spanning medtech, robotics, agtech and AI.
Also Startup Daily·Startup Daily·Startup Daily·Startup Daily·SmartCompany·Startup Daily·Startup Daily
Blackbird's investment note recapping its backing of Coherence Neuro and the neural implant startup's development milestones, institutional collaborations, and path toward first-in-human glioblastoma trials.
Micro-X's Head CT test bench produced its first 3D images, qualifying it for an MRFF progress payment, with US ARPA-H contracts worth $25 million announced this week supporting full-body CT development.
Profile of scientist-entrepreneur Andrew Wilks tracing his path from cancer research to founding drug developer Cytopia and launching SYNthesis BioVentures, a therapeutics fund that recently secured $30 million from wealthy individuals and family offices.
Micro-X will trial its lightweight portable CT brain scanner at two hospitals this year; the Adelaide company's stroke technology was developed with $8 million in grant funding, as was rival EMVision's approach.